News

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...
In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is ...
He also said 'stress can increase the drive to eat', so meditating and going for a short walk might be a good alternative to snacking. For those wanting to explore weight loss medication, he added ...
One person using Mounjaro revealed they had a peculiar ‘magic mushroom’ sensation when starting the medication in a discussion about side effects on Reddit ...
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast ...
Weight loss medications can reduce the efficacy of oral contraceptives. What to know before taking drugs like Ozempic, ...
EXPERTS have revealed there could be a ‘golden dose’ of Mounjaro that helps shift the most weight – and it’s not the highest ...
India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for ...
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.
Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...